Validation of cofilin-1 as a biomarker in non-small cell lung cancer: application of quantitative method in a retrospective cohort
✍ Scribed by Carolina B. Müller; Rafael L. S. de Barros; Mauro A. A. Castro; Fernanda M. Lopes; Rosalva T. Meurer; Adriana Roehe; Guilherme Mazzini; Jane Maria Ulbrich-kulczynski; Felipe Dal-Pizzol; Marilda C. Fernandes; José C. F. Moreira; Léder L. Xavier; Fábio Klamt
- Publisher
- Springer-Verlag
- Year
- 2011
- Tongue
- English
- Weight
- 569 KB
- Volume
- 137
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
We have reported the establishment of a mitomycin-C (MMC)resistant non-small-cell lung-cancer cell line, PC-9/MC4. As determined by an MlT assay, this resistant cell line was found to be 4 times more sensitive to adriamycin (ADM) than was the parental PC-9. There were no significant differences in s
## Abstract We recently reported the development of a multianalyte serum algorithm to identify nodal status in non‐small cell lung cancer (NSCLC) patients facing an anatomic resection with curative intent. This study aims to enhance the overall performance characteristics of this test by adding aut
Accumulation of mutant p53 protein occurs frequently in human malignancies, including 40-60% of non-small cell lung carcinomas. The implications of such p53 over-expression, usually assessed by immunohistochemical techniques, for the prognosis of lung cancer patients remain undetermined. In this stu
## Abstract The pattern of protein expression in tumors is under the influence of nutrient stress, hypoxia and low pH, which determines the survival of neoplastic cells and the development of tumors. Carbonic anhydrase XII (CAXII) is a transmembrane enzyme that catalyzes the reversible hydration of